SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
ASTRO Release: Concurrent Use of Sorafenib and Stereotactic Body Radiotherapy for Advanced Liver Cancer Patients is Not Recommended Outside of Clinical Trials